Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports

Samankaltaisia teoksia

• PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
  Tekijä: di Mauro, Gabriella, et al.
  Julkaistu: (2020)
• Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
  Tekijä: Noda, Aoi, et al.
  Julkaistu: (2020)
• Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
  Tekijä: Moyer, Ann M., et al.
  Julkaistu: (2019)
• Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases
  Tekijä: Tao Wang, et al.
  Julkaistu: (2025-04-01)
• Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century
  Tekijä: Watson, Sarah, et al.
  Julkaistu: (2019)